Semaglutide
GLP-1 Receptor Agonist
Size: 10mg
Volume Discounts Available
3rd Party Tested
99.5% Purity
COA Included
Same Day Ship
Ships from: Sydney, Australia
For Research Use Only — Not for Human Consumption
This product is intended solely for in-vitro laboratory research. Not approved by the FDA, TGA, or any regulatory body for human or animal use.Full Disclaimer
Overview
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed for research into metabolic regulation, glucose homeostasis, and appetite signalling pathways. The peptide exhibits a high degree of homology to native human GLP-1 with modifications for enhanced stability and receptor binding affinity. In laboratory settings, semaglutide serves as a research tool for investigating incretin hormone signalling, pancreatic beta-cell function, and central nervous system pathways involved in satiety and energy homeostasis.
Research Uses
Semaglutide is supplied exclusively for laboratory research use and has been employed in controlled experimental studies examining:
GLP-1 receptor binding and activation studies
Insulin secretion pathway investigation
Glucagon suppression mechanism research
Gastric emptying rate modulation studies
Appetite regulation and satiety signal research
Metabolic pathway mapping in animal models
All applications are limited to non-clinical research systems designed to elucidate fundamental biological mechanisms.
RESEARCH USE ONLY
This product is intended for laboratory research use only. Not for human or veterinary use. All studies utilising this compound must be conducted in controlled research environments by qualified personnel.